Southeast Clinical Research Assoc LLC is categorized under Medical Labs in Charlotte, NC and active since 2010.
Southeast Clinical Research Assoc LLC was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact David S Moss at the company’s single location by writing to 226 Baldwin Avenue, Charlotte, North Carolina NC 28204 or by phoning (704) 945-4111. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Southeast Clinical Research Assoc LLC |
| Contact Person: | David S Moss |
| Address: | 226 Baldwin Avenue, Charlotte, North Carolina 28204 |
| Phone Number: | (704) 945-4111 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Southeast Clinical Research Assoc LLC was started in 2010 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David S Moss for inquiries that concern Southeast Clinical Research Assoc LLC by calling the company number (704) 945-4111, as your correspondence is most welcome. Additionally, the physical location of the single location of Southeast Clinical Research Assoc LLC can be found at the coordinates 35.211585,-80.829917 as well as the street address 226 Baldwin Avenue in Charlotte, North Carolina 28204.
For its online presence, you may visit Southeast Clinical Research Assoc LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.